NCT06458335

Brief Summary

This study aims to enroll 300 participants who will be assigned to one of three 3 groups. Each group will receive an intervention lasting 6, weekly sessions of 40-60 minutes. Eligibility include having an opioid use disorder and reporting loneliness or feeling alone or disconnected.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
38mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Sep 2024Jun 2029

First Submitted

Initial submission to the registry

June 9, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 19, 2024

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2029

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

4.8 years

First QC Date

June 9, 2024

Last Update Submit

December 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean change in loneliness

    Loneliness will be measured using the UCLA Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.

    Baseline to 6 months

  • Mean change in number of days of opioid use

    Participants will complete a calendar indicating the type and frequency of drug use.

    Baseline to 6 months

Secondary Outcomes (3)

  • mean change in social interactions

    Baseline to 6 months

  • Mean change in depression

    Baseline to 6 months

  • Mean change in anxiety

    Baseline to 6 months

Study Arms (3)

Cognitive-Behavioral Therapy

EXPERIMENTAL

CBT delivered over the course of 6, \~45 minute sessions delivered via telehealth

Behavioral: Cognitive-Behavioral Therapy for Perceived Social Isolation

therapist-delivered Health Education

ACTIVE COMPARATOR

Health education sessions delivered over the course of 6, \~45 minute sessions delivered via telehealth.

Behavioral: Health Education

self-guided Health Education

ACTIVE COMPARATOR

Health education sessions that are self-guided over the course of 6 sessions

Behavioral: Health Education

Interventions

6 sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use

Also known as: CBT-PSI
Cognitive-Behavioral Therapy

Health education provides information on the importance and benefits of and guidelines for living a health lifestyle

self-guided Health Educationtherapist-delivered Health Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be 18+
  • understand English -have internet access-
  • screen positive for an opioid use disorder
  • screen positive for elevated loneliness

You may not qualify if:

  • does not understand consent
  • does not have consistent access to a phone and internet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

RECRUITING

MeSH Terms

Conditions

Opioid-Related DisordersSocial Isolation

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersSocial BehaviorBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 9, 2024

First Posted

June 13, 2024

Study Start

September 19, 2024

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

June 30, 2029

Last Updated

December 9, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified participant data is available upon request through a data use agreement as part of scientific collaboration

Locations